Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L F Gram

Showing results (21-30 of 197) with videos related to

Pageof 20
Sort By:
Psychopharmacology Communications|January 1, 1975
Effects of perphenazine on imipramine metabolism in manL F Gram
Acta Psychiatrica Scandinavica. Supplementum|January 1, 1980
Pharmacokinetics and clinical response to tricyclic antidepressantsL F Gram
Ugeskrift for Laeger|November 30, 2000
[Is bone marrow inhibition a special risk in connection with olanzapine (Zyprexa) treatment?]L F Gram
Ugeskrift for Laeger|August 29, 1977
[Adverse effects during treatment with beta receptor blockaders. Report from the Adverse Drug Reaction Committee 1968-1976]L F Gram
Nordisk Psykiatrisk Tidsskrift. Nordic Journal of Psychiatry|January 1, 1971
[Drug interactions: blocking effect of neuroleptics on the metabolism of tricyclic antidepressive agents]L F Gram
British Journal of Clinical Pharmacology|June 1, 1993
Moclobemide treatment causes a substantial rise in the sparteine metabolic ratio. Danish University Antidepressant GroupL F Gram, K Brøsen
Clinical Neuropharmacology|January 1, 1992
Drug interactions and pharmacokinetic risk factors when using antidepressants in the medically ill patientsL F Gram, K Brøsen
Clinical Pharmacology and Therapeutics|April 1, 1988
First-pass metabolism of imipramine and desipramine: impact of the sparteine oxidation phenotypeK Brøsen, L F Gram
The Journal of Pharmacy and Pharmacology|August 1, 1973
Imipramine and its metabolites in human brainJ Christiansen, L F Gram
Psychopharmacology Series|January 1, 1989
Inhibitors of the microsomal oxidation of psychotropic drugs: selectivity and clinical significanceL F Gram, K Brøsen
Pageof 20

Showing results (21-30 of 197) with videos related to

Sort By:
Pageof 20
Psychopharmacology Communications|January 1, 1975
Effects of perphenazine on imipramine metabolism in manL F Gram
Acta Psychiatrica Scandinavica. Supplementum|January 1, 1980
Pharmacokinetics and clinical response to tricyclic antidepressantsL F Gram
Ugeskrift for Laeger|November 30, 2000
[Is bone marrow inhibition a special risk in connection with olanzapine (Zyprexa) treatment?]L F Gram
Ugeskrift for Laeger|August 29, 1977
[Adverse effects during treatment with beta receptor blockaders. Report from the Adverse Drug Reaction Committee 1968-1976]L F Gram
Nordisk Psykiatrisk Tidsskrift. Nordic Journal of Psychiatry|January 1, 1971
[Drug interactions: blocking effect of neuroleptics on the metabolism of tricyclic antidepressive agents]L F Gram
British Journal of Clinical Pharmacology|June 1, 1993
Moclobemide treatment causes a substantial rise in the sparteine metabolic ratio. Danish University Antidepressant GroupL F Gram, K Brøsen
Clinical Neuropharmacology|January 1, 1992
Drug interactions and pharmacokinetic risk factors when using antidepressants in the medically ill patientsL F Gram, K Brøsen
Clinical Pharmacology and Therapeutics|April 1, 1988
First-pass metabolism of imipramine and desipramine: impact of the sparteine oxidation phenotypeK Brøsen, L F Gram
The Journal of Pharmacy and Pharmacology|August 1, 1973
Imipramine and its metabolites in human brainJ Christiansen, L F Gram
Psychopharmacology Series|January 1, 1989
Inhibitors of the microsomal oxidation of psychotropic drugs: selectivity and clinical significanceL F Gram, K Brøsen
Pageof 20